Iovance Biotherapeutics (IOVA) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.45
-0.39
-0.34
-0.28

Details

Expected EPS
-0.298851
Actual EPS
-0.28
Surprise EPS
0.02
Surprise Percent
+6.31%

Description

Iovance Biotherapeutics (IOVA) has reported earnings of -0.28 per share for Q4 2024.

0 Comments

Share your thoughts